Blackstone harnesses the power of AI to manage diabetes and significantly reduce expenditure on medication.
2 min read Blackstone's AI-powered diabetes program, Twin Health, shows early promise with a 90% reduction in drug spending and patients losing an average of 12 pounds in 2 months. Testing with 14 portfolio companies could save hundreds of thousands of dollars in drug costs per year. April 17, 2023 21:20
The age of artificial intelligence is upon us, and Blackstone Inc. is leading the charge with its latest experiment in healthcare. The investment firm is testing a diabetes program that promises to revolutionize the way patients manage their condition. Powered by AI, the program has already yielded promising results, with patients experiencing significant weight loss and a staggering 90% reduction in spending on drugs like Novo's Ozempic.
The program, called Twin Health, offers personalized advice on diet, exercise, and other activities, tailoring its recommendations to each patient's unique needs. It is currently being tested with 14 of Blackstone's portfolio companies, and if successful, could save hundreds of thousands of dollars in drug costs every year. This exciting development is a testament to the potential of AI in healthcare, and with Blackstone leading the way, we can expect to see more innovative solutions emerging in the coming years.
User Comments (0)
Editor's Choice
